A phase 2, multicenter, single-arm of Zanubrutinib
PDF 1 06/2020
Trial in progress: A phase 2, multicenter, single-arm of Zanubrutinib (BGB-3111) in patients with previously treated B-Cell Malignancies intolerant of prior treatment of Ibrutinib or Acalabrutinib